Related Experiment Video
Updated: Mar 12, 2026

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
High red cell distribution width as a prognostic indicator in heart failure.
Sidhartha Gautam Senapati1, Azra Kothawala2, Vibhor Ahluwalia3
1Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, United States. senapati.sidhartha36@gmail.com.
High red cell distribution width (RDW) significantly increases mortality risk in heart failure (HF) patients. This finding highlights RDW as a valuable biomarker for HF prognosis and risk stratification.
Area of Science:
- Cardiology
- Hematology
- Clinical Biomarkers
Background:
- Red cell distribution width (RDW) quantifies red blood cell size variability.
- Elevated RDW is linked to adverse health outcomes, including cardiovascular diseases.
Purpose of the Study:
- To evaluate the prognostic significance of high red cell distribution width (RDW) in patients diagnosed with heart failure (HF).
Main Methods:
- A systematic literature search was performed across PubMed, EMBASE, and Google Scholar up to May 2024.
- Seven studies comprising 11,460 heart failure patients were included in this meta-analysis.
- All-cause mortality was the primary outcome, with heterogeneity and publication bias assessed.
Main Results:
- Patients in the highest RDW quartile (>15.21%) faced a 1.84-fold increased risk of all-cause mortality compared to the lowest quartile.
- Significant heterogeneity (I²=93%) and potential publication bias were noted.
- Sensitivity analyses confirmed the robustness of the findings.
Conclusions:
- High RDW is a reliable predictor of adverse outcomes in heart failure patients.
- RDW serves as a simple, cost-effective biomarker for risk stratification in HF.
- Further research is needed to explore RDW's underlying mechanisms and therapeutic implications in HF.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Heart Failure II: Pathophysiology
Rheumatic Heart Disease IV: Nursing Management
Pathophysiology of Heart Failure
Cardiomyopathy II: Dilated Cardiomyopathy

